Australia's most trusted
source of pharma news
Posted 8 May 2024 PM
An industry-backed hub for radiopharmaceutical medicines has officially opened today on the grounds of the University Queensland (UQ), marking yet another step towards positioning Australia at the forefront of the rapidly growing market.
AMTAR hub Director Kris Thurecht |
The Australian Research Council (ARC) hub for Advanced Manufacture of Targeted Radiopharmaceuticals (AMTAR) is a one-stop-shop for biotech firms offering expertise and equipment to design, test and deliver groundbreaking precision cancer treatments.
Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.